Kuros Biosciences AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18.44	18.02	14.21	24.07	28.62	28.39
Cash & Short-Term Investments	18.44	18.02	14.21	24.07	28.62	28.39
Cash Growth	29.17%	26.84%	-40.96%	-15.92%	0.83%	36.47%
Accounts Receivable	21.78	13.4	6.41	2.82	1.69	1.04
Other Receivables	5.11	2.75	1.21	0.8	0.36	0.37
Receivables	26.89	16.14	7.62	3.62	2.05	1.4
Inventory	13.71	9.44	4.86	3.17	1.76	1.46
Prepaid Expenses	1.71	1.15	0.51	0.54	0.47	0.55
Other Current Assets	-	-	-	-	-	2.17
Total Current Assets	60.75	44.75	27.19	31.39	32.89	33.97
Property, Plant & Equipment	4.18	3.02	2.64	2.32	2.45	2.59
Goodwill	24.24	19.43	24.47	29.31	33.39	33.85
Other Intangible Assets	17.57	14.99	16.51	19.41	22.61	23.67
Long-Term Deferred Tax Assets	3.19	2.34	0.64	0.5	-	0.3
Other Long-Term Assets	0.04	-	0.01	-	-	-
Total Assets	109.97	84.54	71.46	82.95	91.34	94.36
Accounts Payable	6.92	6.91	1.3	1.3	0.85	0.94
Accrued Expenses	19.42	13.46	7.93	5.03	3.6	2.59
Current Portion of Leases	0.65	0.53	0.58	0.42	0.38	0.35
Other Current Liabilities	-	-	-	5.84	6.46	-
Total Current Liabilities	26.99	20.9	9.81	12.59	11.29	3.88
Long-Term Leases	1.14	1.26	1.57	1.5	1.83	2.06
Pension & Post-Retirement Benefits	-	0.14	-	-	0.35	0.59
Long-Term Deferred Tax Liabilities	1.61	0.33	-	-	0.89	3.24
Other Long-Term Liabilities	3.58	3.16	3.38	-	-	-
Total Liabilities	33.32	25.79	14.75	14.09	14.36	9.76
Common Stock	3.15	3.79	3.68	3.66	3.28	32.81
Additional Paid-In Capital	65.98	73.03	73.32	160.16	154.59	125.06
Retained Earnings	-42.6	-44.45	-42.15	-115.83	-101.59	-94.27
Treasury Stock	-	-	-0.02	-0.02	-0.02	-0.02
Comprehensive Income & Other	50.12	26.39	21.89	20.9	20.71	21.02
Shareholders' Equity	76.65	58.75	56.71	68.86	76.98	84.6
Total Liabilities & Equity	109.97	84.54	71.46	82.95	91.34	94.36
Total Debt	1.79	1.79	2.14	1.91	2.21	2.41
Net Cash (Debt)	16.65	16.23	12.07	22.15	26.41	25.98
Net Cash Growth	35.23%	34.51%	-45.53%	-16.12%	1.66%	41.45%
Net Cash Per Share	0.37	0.44	0.33	0.65	0.81	1.07
Filing Date Shares Outstanding	40.26	37.87	36.77	36.54	32.79	32.79
Total Common Shares Outstanding	40.26	37.87	36.77	36.54	32.79	32.79
Working Capital	33.76	23.86	17.38	18.8	21.6	30.09
Book Value Per Share	1.90	1.55	1.54	1.88	2.35	2.58
Tangible Book Value	34.84	24.32	15.74	20.13	20.98	27.09
Tangible Book Value Per Share	0.87	0.64	0.43	0.55	0.64	0.83
Machinery	4.45	2.82	1.75	1.51	1.18	0.94
Leasehold Improvements	0.08	0.06	0.04	0.04	0.04	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.